1
|
Bethencourt-Baute JJ, Montero N, Zacarias AM, Nieto JC, López-Corbeto M, Boteanu A, Medrano M, Díaz-Cordovés Rego G, Vargas-Lebron C, Machín-García S, Expósito L, Cacheda AP, Bernabeu P, Veroz-González R, Fernández O, Enriquez Merayo E, Torrente-Segarra V, Fernández-Alba MD, Gamir ML, López-Robledillo JC, Antón J, Otero L, Bustabad S. Juvenile idiopathic arthritis in the young adult. Methodology, objectives, and initial data from the JUVENSER registry. REUMATOLOGIA CLINICA 2023:S2173-5743(23)00101-6. [PMID: 37258400 DOI: 10.1016/j.reumae.2023.01.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/16/2023] [Accepted: 01/30/2023] [Indexed: 06/02/2023]
Abstract
OBJECTIVES To describe the methodology, objectives, and initial data of the registry of young adult patients diagnosed with Juvenile Idiopathic Arthritis (JIA), JUVENSER. The main objective of the project is to know the sociodemographic and clinical characteristics, and disease activity of patients with JIA reaching the transition to adulthood. MATERIAL AND METHOD Longitudinal, prospective, multicentre study, including patients between 16 and 25 years old, with a diagnosis of JIA in any of its categories. The main objective is to determine the characteristics and activity of JIA in the young adult. It includes sociodemographic variables, clinical variables, disease activity and joint damage rates, data on the use of health resources, and treatments used. The total duration of the project will be 3 years. A cohort of 534 young adult patients was obtained. CONCLUSIONS The JUVENSER registry will constitute a cohort of young adults with JIA, which will allow the evaluation of the clinical characteristics and response to treatment of patients with disease onset in childhood, moving to adult clinics.
Collapse
Affiliation(s)
| | - Nuria Montero
- Unidad de Investigación, Sociedad Española de Reumatología, Madrid, Spain
| | - Andrea M Zacarias
- Unidad de Transición, Hospital Sant Joan de Déu. Hospital Clínic de Barcelona, Barcelona, Spain
| | - Juan Carlos Nieto
- Servicio de Reumatología, Hospital General Gregorio Marañón, Madrid, Spain
| | | | - Alina Boteanu
- Servicio de Reumatología, Hospital Universitario Ramón y Cajal, Madrid, Spain
| | - Marta Medrano
- Servicio de Reumatología, Hospital Universitario Miguel Servet, Zaragoza, Spain
| | | | - Carmen Vargas-Lebron
- Servicio de Reumatología, Hospital Universitario Virgen Macarena, Sevilla, Spain
| | - Sergio Machín-García
- Servicio de Reumatología, Complejo Hospitalario Insular Materno Infantil, Las Palmas de Gran Canaria, Spain
| | - Lorena Expósito
- Servicio de Reumatología, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain
| | - Ana Paula Cacheda
- Servicio de Reumatología, Hospital Universitario Son Llàtzer, Mallorca, Spain
| | - Pilar Bernabeu
- Servicio de Reumatología, Hospital General Universitario de Alicante, Alicante, Spain
| | | | - Olaia Fernández
- Servicio de Reumatología, Hospital Universitario de Basurto, Bilbao, Spain
| | | | - Vicenç Torrente-Segarra
- Servicio de Reumatología, Hospital Comarcal Alt Penedés Garraf, Vilafranca del Penedès, Spain
| | | | - María Luz Gamir
- Servicio de Reumatología, Hospital Universitario Ramón y Cajal, Madrid, Spain
| | | | - Jordi Antón
- Servicio de Reumatología, Hospital Sant Joan de Déu, Barcelona, Spain
| | - Lucía Otero
- Unidad de Investigación, Sociedad Española de Reumatología, Madrid, Spain
| | - Sagrario Bustabad
- Servicio de Reumatología, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain
| |
Collapse
|
2
|
Oommen PT, Strauss T, Baltruschat K, Foeldvari I, Deuter C, Ganser G, Haas JP, Hinze C, Holzinger D, Hospach A, Huppertz HI, Illhardt A, Jung M, Kallinich T, Klein A, Minden K, Mönkemöller K, Mrusek S, Neudorf U, Dückers G, Niehues T, Schneider M, Schoof P, Thon A, Wachowsky M, Wagner N, Bloedt S, Hofer M, Tenbrock K, Schuetz C. Update of evidence- and consensus-based guidelines for the treatment of juvenile idiopathic arthritis (JIA) by the German Society of Pediatric and Juvenile Rheumatic Diseases (GKJR): New perspectives on interdisciplinary care. Clin Immunol 2022; 245:109143. [DOI: 10.1016/j.clim.2022.109143] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2022] [Revised: 09/26/2022] [Accepted: 09/27/2022] [Indexed: 11/15/2022]
|
3
|
Haas JP, Arbogast M. [Therapeutic options in juvenile idiopathic arthritis : Part 1: Nonsurgical treatment]. DER ORTHOPADE 2019; 47:912-918. [PMID: 30291372 DOI: 10.1007/s00132-018-3645-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Abstract
The treatment of children and adolescents with juvenile idiopathic arthritis (JIA) has progressed substantially during recent years. Multiple different factors have played a role in this advancement: improved medical treatment due to the introduction of new drugs, structural improvements with provision of units specializing in childhood rheumatology, multidisciplinary treatment concepts, structured educational programs for patients and parents, improved functional treatment including sports therapy, and selective surgical and orthopedic interventions improving functional capacities. Current treatment strategies in JIA are aimed at achieving disease remission, i.e., control of disease activity and re-establishment of age-appropriate functional capacities. This review summarizes important developments in the conservative treatment of JIA. Part 2 deals with orthopedic and surgical treatment strategies.
Collapse
Affiliation(s)
- J-P Haas
- Deutsches Zentrum für Kinder- und Jugendrheumatologie, Kinderklinik Garmisch-Partenkirchen gGmbH, Gehfeldstr. 24, 82467, Garmisch-Partenkirchen, Deutschland.
| | - M Arbogast
- Abteilung für Rheumaorthopädie und Handchirurgie, Zentrum für Rheumatologie, Orthopädie und Schmerztherapie, Klinik Oberammergau, Oberammergau, Deutschland
| |
Collapse
|
4
|
Luque Ramos A, Hoffmann F, Albrecht K, Klotsche J, Zink A, Minden K. Transition to adult rheumatology care is necessary to maintain DMARD therapy in young people with juvenile idiopathic arthritis. Semin Arthritis Rheum 2017; 47:269-275. [PMID: 28583690 DOI: 10.1016/j.semarthrit.2017.05.003] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2017] [Revised: 05/08/2017] [Accepted: 05/10/2017] [Indexed: 01/15/2023]
Abstract
OBJECTIVE To evaluate the outpatient health service utilisation of young people (YP) with juvenile idiopathic arthritis (JIA) during transfer from paediatric to adult care in Germany. METHODS Based on claims data of a large German statutory health fund (BARMER GEK) we conducted a cohort study of 2008-2014. Insured YP with diagnosis of JIA (ICD: M08 or M09.0) in two quarters at the age of 16 and continuous insurance until the age of 20 were included. Outpatient health care utilisation, prescribed antirheumatic drugs and diagnosis maintenance were analysed over four consecutive years for all YP with JIA and for the subgroup on disease-modifying antirheumatic drugs (DMARDs) at the age of 16. RESULTS A total of 256 YP with JIA (67% female) were followed during the transfer period, 115 of them received (DMARDs) at the age of 16. At the age of 20, 30% of all 256 YP utilised adult specialty care, 59% still had a JIA diagnosis and 30% were treated with DMARDs. Of those 115 YP, treated with DMARDs at the age of 16 and in need of follow-up, 49% had visited an adult rheumatologist at the age of 20, 75% had a JIA diagnosis and 56% were on DMARDs. Those 49% YP with successful transfer to adult specialty care had a JIA diagnosis in 93% and were treated with DMARDs in 80%. YP, who were only seen by general practitioners, had a JIA diagnosis in 54% and received DMARDs in 27%. CONCLUSIONS One in two YP with JIA and a clear need for ongoing follow-up do not utilise adult rheumatologic care. The maintenance of JIA diagnosis and DMARD therapy depend on the utilisation of specialised care services.
Collapse
Affiliation(s)
- Andres Luque Ramos
- Department of Health Services Research, Carl von Ossietzky University, Oldenburg, Ammerländer Heerstrasse 140, 26111, Germany.
| | - Falk Hoffmann
- Department of Health Services Research, Carl von Ossietzky University, Oldenburg, Ammerländer Heerstrasse 140, 26111, Germany
| | - Katinka Albrecht
- Department of Epidemiology, German Rheumatism Research Centre, Berlin, Germany
| | - Jens Klotsche
- Department of Epidemiology, German Rheumatism Research Centre, Berlin, Germany; Charité University Medicine, Berlin, Germany
| | - Angela Zink
- Department of Epidemiology, German Rheumatism Research Centre, Berlin, Germany; Charité University Medicine, Berlin, Germany
| | - Kirsten Minden
- Department of Epidemiology, German Rheumatism Research Centre, Berlin, Germany; Charité University Medicine, Berlin, Germany
| |
Collapse
|
5
|
Abstract
Childhood onset rheumatic and musculoskeletal diseases often continue into adulthood. These diseases are associated with a high risk of permanent disability and impairment in the quality of life of people affected. Adolescence and young adulthood represent a particular risk phase for an unfavorable long-term outcome. During this challenging and future health-determining phase at least one in three patients stops seeking regular specialized healthcare and the health status of these people deteriorates after having left pediatric care. The key principles of transitional care have been defined, are generally accepted and are presented in this article. There is emerging evidence of the effectiveness of transitional care programs. The implementation of a structured transition into the routine care of adolescents and young adults with rheumatic diseases is necessary.
Collapse
|
6
|
Consensus of the Spanish society of pediatric rheumatology for transition management from pediatric to adult care in rheumatic patients with childhood onset. Rheumatol Int 2015; 35:1615-24. [PMID: 25917856 DOI: 10.1007/s00296-015-3273-6] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2015] [Accepted: 04/16/2015] [Indexed: 10/23/2022]
Abstract
To develop recommendations on the transition from pediatric care to adult care in patients with chronic inflammatory rheumatic diseases with childhood onset based. Recommendations were generated following nominal group methodology and Delphi technique. A panel of 16 experts was established. A systematic literature review (on transitional care) and a narrative review were performed and presented to the panel in the first panel meeting to be discussed. A first draft of recommendations was generated and circulated. Focal groups with adolescents, young adults and parents were organized. In a second meeting, the focus group results along with the input from invited psychologist were used to establish definitive recommendations. Then, a Delphi process (two rounds) was carried out. A group of 72 pediatric and adult rheumatologists took part. Recommendations were voted from 1 (total disagreement) to 10 (total agreement). We defined agreement if at least 70 % voted ≥7. The level of evidence and grade or recommendation was assessed using the Oxford center for evidence-based medicine levels of evidence. Transition care was defined as a purposeful, planned process that addresses the medical, psychosocial and educational/vocational needs of adolescents and young adults with chronic inflammatory rheumatic diseases with childhood onset as they move from child-centered to adult-oriented healthcare systems. The consensus covers: transition needs, barriers and facilitators, transitional issues (objectives, participants, content, phases, timing, plans, documentation and responsibilities), physicians' and other health professionals' knowledge and skill requirements, models/programs, and strategies and guideline for implementation. Preliminary recommendations and agreement grade are shown in the Table (first Delphi round). These recommendations are intended to provide health professionals, patients, families and other stakeholders with a consensus on the transition process from pediatric to adult care.
Collapse
|